跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 84 条关于
“Agomab”
全部
84
临床试验
31
药物
30
机构
3
资讯
20
去年
Agomab Therapeutics Secures $89 Million to Advance Fibrotic Disease Treatments
8个月前
Agomab and SpyGlass Raise Combined $350M in Biotech IPOs, Signaling Market Recovery
8个月前
Agomab Therapeutics Raises $200 Million in IPO to Advance Fibrotic Disease Therapies
2个月前
Agomab Unveils Design for First-Ever Phase 2b Trial in Fibrostenosing Crohn's Disease with Oral ALK5 Inhibitor Ontunisertib
去年
Agomab's AGMB-129 Shows Promising Results in Phase 2a Trial for Fibrostenosing Crohn's Disease
10个月前
Agomab's Ontunisertib Achieves Primary Safety Endpoint in First-in-Class Phase 2a Trial for Fibrostenosing Crohn's Disease
11个月前
TGF-β Inhibitor Pipeline Expands with 25+ Companies Developing Novel Therapies for Cancer and Fibrosis
去年
Antifibrotic Drug Development Gains Momentum with $3B+ in Deals and Breakthrough Clinical Results
6个月前
Generate Biomedicines Targets $2.2 Billion Valuation in IPO as AI Drug Discovery Platform Advances Severe Asthma Therapy
5个月前
Frontier Medicines Appoints Former Seagen CEO David Epstein to Board as Company Advances Covalent Precision Medicine Pipeline
第 1 页,共 2 页
上一页
下一页